Paliperidone Tablet, Extended Release
Product Images NDC 42291-915

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 42291-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (915 30)

Paliperidone Extended-Release Tablets 1.5 mg oral tablets label by AvKARE. The label indicates 30 tablets in the package and states the tablets should be swallowed whole without dividing, crushing, or chewing. It includes storage instructions and manufacturer details for AvKARE in Pulaski, TN.*

FDA Label Image

30 (916 30)

Label for Paliperidone Extended-Release Tablets 3 mg by AvKARE, containing 30 tablets. Instructions indicate tablets should be swallowed whole and not divided, crushed, or chewed. Each tablet contains 3 mg of paliperidone USP. The label includes storage instructions and contact information for the manufacturer located in Pulaski, TN.*

FDA Label Image

30 (917 30)

Label for Paliperidone Extended-Release Tablets 6 mg by AvKARE. The label shows 30 tablets in an oral extended-release tablet form. Instructions indicate tablets should be swallowed whole without dividing, crushing, or chewing. The label includes storage information, dosage caution, and manufacturing details from AvKARE in Pulaski, TN.*

FDA Label Image

30 (918 30)

Label for Paliperidone Extended-Release Tablets 9 mg by AvKARE. The label specifies that tablets should be swallowed whole and not divided, crushed, or chewed. The package contains 30 tablets. Storage instructions and dispensing information are also included, along with the AvKARE logo and NDC 42291-918-30.*

FDA Label Image

Chem Structure (Paliperidone Extended Release Tablets 1)

Chemical structure of paliperidone, showing its molecular composition with labeled atoms and bonds arranged in a complex ring and chain formation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.